Official Title
The Genetic Evolution and Microenvironment of Multiple Primary Lung Cancer
Brief Title
Evolution of Multiple Primary Lung Cancer (Evolution)
Protocol ID
NCT04326751
Lead Sponsor
Peking University People's Hospital
Brief Summary
To investigate the evolutionary genomic landscape, explore the genetic tumor
heterogeneity and microenvironment of multiple primary lung cancer (MPLC) by using tissue
genetic analysis and circulating tumor DNA detection, in order to provide robust evidence
for the diagnosis, treatment, and surveillance of MPLC.
Detailed Description
Multiple primary lung cancer (MPLC) has become a worldwide problem due to the difficulty
in diagnosis, treatment and surveillance. Although exploring tumour clonal heterogeneity
and microenvironment can help understand cancer evolution and impact therapeutic outcome,
study is still lacking in this field on MPLC. Circulating tumor DNA (ctDNA) are short DNA
fragments, which can be obtained conveniently and non-invasively, providing comprehensive
views of the tumor as were shed by tumor cells from multiple tumor regions. Therefore, we
design a prospective study of patients with surgically treated MPLC, aiming to use ctDNA
technique to define the evolutionary landscape of MPLC through inter-tumor and
intra-tumor heterogeneity by multi-region sampling and genetic analysis. We will also
explore the the microenvironment by RNA sequencing and T cell receptor sequencing. This
study may help understand the genetic evolution and microenvironment of MPLC, and provide
evidence for the diagnosis, treatment and surveillance of these patients.
Study Period
-
Enrollment Count
20 participants
Eligibility Criteria
Inclusion Criteria:
- Aged 18 to 80 years
1. Patients who are clinically diagnosed multiple lung cancers, and undergo
surgical treatment.
2. No history of any malignancy in recent 5 years.
3. No chemotherapy, radiotherapy or targeted therapy will be performed before
surgery.
4. Surgical removal of at least 2 tumors confirmed to be lung cancer
postoperatively by pathologic evaluation.
Exclusion Criteria:
1. All lesions present as pure ground-glass opacities (GGOs) on CT scans.
2. Patients who do not undergo R0 resection (including tumors located bilaterally but
only unilaterally resected).
3. Unqualified blood samples.
4. Unable to comply with the study procedure
Filters
Multiple Primary Lung Cancers
Lung Cancer
Non Small Cell Lung Cancer
UNKNOWN
ADULT
OLDER_ADULT